Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization
about
Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary DysplasiaAlveologenesis: key cellular players and fibroblast growth factor 10 signalingEndogenous and Exogenous Stem/Progenitor Cells in the Lung and Their Role in the Pathogenesis and Treatment of Pediatric Lung DiseaseStem cell-based therapies for the newborn lung and brain: Possibilities and challengesStem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary DysplasiaAnimal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung DiseaseBench-to-bedside review: the effects of hyperoxia during critical illnessThe Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series)Effect of two models of intrauterine growth restriction on alveolarization in rat lungs: morphometric and gene expression analysisRole of Nitric Oxide Isoforms in Vascular and Alveolar Development and Lung Injury in Vascular Endothelial Growth Factor Overexpressing Neonatal Mice LungsUnique aspects of the developing lung circulation: structural development and regulation of vasomotor toneSuppression of inflammatory cell trafficking and alveolar simplification by the heme oxygenase-1 product carbon monoxideResolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injuryMaternal exposure to endotoxin delays alveolarization during postnatal rat lung developmentProlonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice.Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification.Analysis of circulating hem-endothelial marker RNA levels in preterm infants.Lasers, stem cells, and COPD.Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasiaSelective gene expression analysis of the neuroepithelial body microenvironment in postnatal lungs with special interest for potential stem cell characteristics.Developmental determinants and changing patterns of respiratory outcomes after preterm birth.The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.Chronic lung disease in the preterm infant. Lessons learned from animal modelsSildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway.Sustained hyperoxia-induced NF-κB activation improves survival and preserves lung development in neonatal mice.Pulmonary vascular changes in extremely preterm sheep after intra-amniotic exposure to Ureaplasma parvum and lipopolysaccharidePartial pulmonary embolization disrupts alveolarization in fetal sheep.Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia.Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration.Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity.Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growthOxygen differentially affects the hox proteins Hoxb5 and Hoxa5 altering airway branching and lung vascular formation.Persistently elevated right ventricular index of myocardial performance in preterm infants with incipient bronchopulmonary dysplasiaThe thioredoxin system in neonatal lung diseaseThymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic miceModerate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin.Role of EC-SOD overexpression in preserving pulmonary angiogenesis inhibited by oxidative stress.
P2860
Q26744473-7609B535-5A8A-482C-B915-0560E15271B5Q26751435-ABEEE79A-7DC5-46E5-8D6F-39D7388E294AQ26752355-7D470279-27B9-4053-8A2A-F20DDD5B568CQ26771562-F5C4E78D-13CF-4D2C-A301-EEDB5D6895C2Q26797261-73F6F4FD-91CC-4687-80A6-604AB4D6880AQ26798069-F4DC3871-463A-43A2-B3CE-8B0243F9D66EQ26798077-0D8D6B8B-0716-4F74-99B1-603124A05707Q26862046-4B70BF22-145D-45EE-AF85-9A37639C8CB3Q27303463-13227722-82BF-457F-860C-B6D74FDA35ADQ27325721-CE0FE304-3CD5-408B-96F2-51B2A67CF968Q28076917-ACED5883-9587-4616-B6DA-B3221F48CBA5Q28384205-265C7616-D888-40B4-96A3-49EA0E339637Q28539312-0426CAA9-36D5-4897-8507-99CA7B7CB7B9Q28574466-8F960C45-1D7D-4258-9163-1D01931E52FEQ30492774-20B597E0-34FE-42B2-B476-32FB86BD905BQ30544045-A5E53D15-6F56-4AFA-86E0-CCB1CA9CA4F6Q33293918-B32A73DC-AC50-4CA2-8333-8ECCF101BE16Q33474572-B49E40C5-46E5-4099-905D-FCF67F8F63A8Q33531541-022317DC-3CC8-4BF9-913C-5189D128313DQ33622213-1C835818-D12D-4012-9B19-F419DA1B0DA6Q33651475-CDAAEE33-49FF-486F-8493-3192069C1F9AQ33699711-B9C66F0B-B1E4-477A-9C5B-4064C0CA15DEQ33711647-92C56391-7DD8-431F-B78F-E8CBD77BFF94Q33746190-D88E9825-8588-443B-9AC3-754C06B354A7Q33756577-E4F69628-DCF3-4927-9B67-33C41E8AAC59Q33756664-360ED5EF-9083-4462-AA85-37531682E491Q33764746-1E9911D5-8FBB-4551-88CB-ACECA8834360Q33860114-E3ED2AC5-4C61-4479-8D33-6043E0DE0C00Q33866405-1888B970-B60A-4079-8941-2DC1B90098DBQ34001672-27756272-1004-437F-B898-0EA648898779Q34003028-E5B143F6-8D48-4422-9D88-AB047718459EQ34119241-EF4369A3-7FC4-4AE5-9CBE-CF7E9B688B70Q34166637-DA60704F-943D-4A0C-A143-3A0E5CB359A4Q34172135-2344BAE5-3D52-4278-8173-CBE1EEB06C2CQ34195890-47377216-E028-4B92-8674-C09302085F73Q34295848-C3FC64F1-DF04-4C68-A536-E59F9C361D29Q34370090-A672136E-6B4D-4B46-8DB5-319A974C764FQ34393516-DD711F26-C410-4AAC-BB64-EA45BE10B7F1Q34426107-1E343B06-94A5-415B-8D6C-A78A95AC6342Q34532596-14C4A841-4DA0-4004-BAC1-8CAB4746A8AE
P2860
Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization
description
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Oktober 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/10/18)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/10/18)
@nl
наукова стаття, опублікована в жовтні 2005
@uk
مقالة علمية (نشرت في 18-10-2005)
@ar
name
Vascular endothelial growth fa ...... articipates in alveolarization
@ast
Vascular endothelial growth fa ...... articipates in alveolarization
@en
Vascular endothelial growth fa ...... articipates in alveolarization
@nl
type
label
Vascular endothelial growth fa ...... articipates in alveolarization
@ast
Vascular endothelial growth fa ...... articipates in alveolarization
@en
Vascular endothelial growth fa ...... articipates in alveolarization
@nl
prefLabel
Vascular endothelial growth fa ...... articipates in alveolarization
@ast
Vascular endothelial growth fa ...... articipates in alveolarization
@en
Vascular endothelial growth fa ...... articipates in alveolarization
@nl
P2093
P3181
P1433
P1476
Vascular endothelial growth fa ...... articipates in alveolarization
@en
P2093
Alois Haromy
Bernard Thébaud
Evangelos D. Michelakis
Farah Eaton
Faruqa Ladha
Gavin Thurston
Greg Korbutt
Gwyneth Harry
Kyoko Hashimoto
Monika Sawicka
P304
P3181
P356
10.1161/CIRCULATIONAHA.105.541524
P407
P577
2005-10-18T00:00:00Z